To further validate the association between USP22 expression and poor prognosis in melanoma, we performed Kaplan–Meier analysis and found that elevated USP22 expression is significantly linked with shortened overall survival and disease‐specific survival (Figure 1D). Here, USP22 is linked to melanoma.